Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2651-2656

  Hsieh, Ming Li ^a   Charlesworth, M Cristine ^a   Goodmanson, Marcia ^a   Zhang, Shaobo ^a   Seay, Thomas ^a   Klee, George G ^a   Tindall, Donald J ^a   Young, Charles Y F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; GLUCOCORTICOID; KALLIKREIN; MINERALOCORTICOID; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE;

ANTIBODY DETECTION; ARTICLE; BINDING AFFINITY; BREAST CANCER; DIAGNOSTIC VALUE; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN EXPRESSION;

BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; IMMUNOASSAY; KALLIKREINS; MALE; PROSTATE-SPECIFIC ANTIGEN; STEROIDS; TISSUE KALLIKREINS; TUMOR CELLS, CULTURED;

EID: 0030788314     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Papsidero, L. D., Kuriyma, M., Wang, M. C., Horosewicz, J., Leong, S. S., Valenzuela, L., Murphy, G. P., and Chu, T. M. Prostate antigen: a marker for human prostate epithelial cells. J. Natl. Cancer Inst., 66: 37-41, 1981.
2. Lilja, H. A. Kallikrein-like serine protease in prostate fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest., 76: 1899-1903, 1985.
3. Watt, K. W. K., Lee, P-J., M'Timkulu, T., Chan, W-P., and Loor, R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl. Acal. Sci. USA, 83: 3166-3170, 1986.
4. Stanley, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., and Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317: 909-916, 1987.
5. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Caplen, D. E., Yuan, J. J., Petros, J. A., and Andriole, G. L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 324: 1156-1161, 1991.
6. Frazer, H. A., Humphrey, P. A., Burchette, J. L., and Paulson, D. F. Immunoreactive prostatic antigen in male periurethral glands. J. Urol., 147: 246-248, 1992.
7. Iwakiri, J., Grandbois, K., Wehner, N., Graves, H. C. B., and Stamey, T. An analysis of urinary prostatic specific antigen before and after radical prostatectomy: evidence for secretion of prostatic specific antigen by the periurethral glands. J. Urol., 149: 783-786, 1993.
8. Elgamal, A. A., Voorde, W. V., Poppel, H. V., Lauweryns, J., and Baert, L. Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Litre, and Morgagni. Urology, 44: 84-90, 1994.
9. Yu, H., Diamandis, E. P., Zarghami, N., and Grass, L. Induction of prostate-specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res. Treat., 32: 291-300, 1994.
10. Yu, H., Diamandis, E. P., and Sutherland, D. J. A. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin. Biochem., 27: 75-79, 1994.
11. Diamandis, E. P., Yu, H., and Sutherland, D. J. A. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res. Treat., 32: 301-310, 1994.
12. Yu, H., Giai, M., Diamandis, E. P., Katsaros, D., Sutherland, D. J. A., Levesque, M. A., Roagna, R., Ponzone, R., and Sismondi, P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res., 55: 2104-2110, 1995.
13. Clements, A., and Mukhtar, A. Glandular kallikrein and prostatic specific antigen are expressed in the human endometrium. J. Clin. Endocrinol. Metab., 78: 1536-1539, 1994.
14. Yu, H., and Diamandis, E. P. Prostate specific immunoreactivity in amniotic fluid. Clin. Chem., 41: 204-210, 1995.
15. Yu, H., and Diamandis, E. P. Prostate specific antigen in milk of lactating women. Clin. Chem., 41: 54-60, 1994.
16. Clements, J. The human kallikrein gene family: a diversity of expression and function. Mol. Cell Endocrinol., 99: C1-C6, 1994.
17. Schedlich, L. J., Bennetts, B. H., and Morris, B. J. Primary structure of a human glandular kallikrein gene. DNA, 6: 429-437, 1987.
18. Young, C. Y. F., Andrews, P. E., Montgomery, B. T., and Tindall, D. J. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry, 31: 818-824, 1992.
19. Murtha, P., Tindall, D. J., and Young, C. Y. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry, 32: 6459-6464, 1993.
20. Young, C. Y. F., Andrews, P. E., and Tindall, D. J., Expression and androgenic regulation of human prostate-specific kallikrein, J. Androl., 16: 97-99, 1995.
21. Saedi, M. S., Cass, M. M. J., Goel, A. S., Grauer, L., Hogen, K. L., Okaneya, T., Griffin, B. Y., Klee, G. G., Young, C. Y. F., and Tindall, D. J. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol. Cell. Endocrinol., 109: 237-241, 1995.
22. Grauer, L. S., Charlesworth, M. C., Saedi, M. S., Finlay, J. A., Liu, R-S., Kuus-Reichel, K., Young, C. Y. F., and Tindall, D. J. Identification of human glandular kallikrein hK2 from LNCaP cells. J. Androl., 17: 353-359, 1996.
23. Young, C. Y. F., Seay, T., Hogen, K., Charlesworth, M. C., Roche, P. C., Klee, G. G., and Tindall, D. J. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer. Prostate, 7: 17-24, 1996.
24. Charlesworth, C. M., Young, C. Y. F., Klee, G. G., Saedi, M. S., Mikolajczyk, S. D., Finlay, J. A., and Tindall, D. J. Detection of a prostate-specific protein, human glandular, kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Urology, 49: 487-493, 1997.
25. Kumar, A., Goel, A. S., Hill, T. M ., Mikolajczyk, S. D., Millar, L. S., Kuus-Reichel, K., and Saedi, M. S. Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res., 56: 5397-5402, 1996.
26. Rittenhouse, H., Tindall, D. J., Klee, G., Young, C. Y. F., Bostwick, D., Saedi, M. S., Grauer, L. S., Mikolajczyk, S. D., Finlay, J. A., Kuus-Reichel, K., Kumar, A., and Wolfert, R. Characterization and evaluation of hK2, a potential prostate cancer marker, closely related to PSA. Proc. 1st Int. Consult. Prostate Cancer, in press, 1997.
27. Sensabaugh, G. F., and Blake, E. T. Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen. J. Urol., 144: 1523-1526, 1990.
28. Beato, M. Gene regulation by steroid hormones. Cell, 56: 335-344, 1989.
29. Kumar, M. V., Leo, M. E., and Tindall, D. J. Modulation of androgen receptor transcriptional activity by the estrogen receptor. J. Androl., 15: 534-542, 1994.
30. Thorpe, S. M. Estrogen and progesterone receptor determinations in breast cancer. Acta Oncol., 27: 1-18, 1988.
31. Fisher, E. R., Redmond, C., Fisher, B., Bass, G., and contributing NSABP investigators. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP), prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients. Cancer (Phila.), 65: 2121-2128, 1990.
32. Kuenen-Boumeester, V., Van der Kwast, T. H., van Putten, W. L. J., Claassen, C., van Ooijen, B., and Henzen-Logmans, S. C. Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int. J. Cancer, 52: 581-584, 1992.
33. Dauvois, S., Geng, S. C., Levesque, C., Merand, Y., and Labrie, F. Additive inhibitory effects of an androgen and antiestrogen EM-170 on estrogen-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res., 51: 3131-3135, 1991.
34. de Launoit, Y., Dauvois, S., Dufour, M., Simard, J., and Labrie, F. Inhibition of cell cycle kinetics and proliferation by the androgen 5α-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16′α-chloro-3′,17β-dihydroxy- estra-1′,3′,5′-(10′)triene-7′ α-yl] undecanamide in human breast cancer ZR-75-1 cells. Cancer Res., 51: 2797-2802, 1991.
35. Lilja, H., Oldbring, J., Rannevik, G., and Laurell, C-B, Seminal vesicle-secretion proteins and their reactions during gelation liquification of human semen. J. Clin. Invest., 80: 281-285, 1993.
36. Cohen, P., Graves, H. C. B., Peehl, D. M., Kamarei, M., Giudice, L. C., and Rosenfeld, R. G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75: 1046-1053, 1992.
37. Dube, J. Y. Prostatic kallikreins: biochemistry and physiology. Comp. Biochem. Physiol., 107C: 13-20, 1994.